Results 211 to 220 of about 711,467 (262)
Some of the next articles are maybe not open access.
Cardiology in Review, 2012
Carcinoid tumors are rare, indolent neuroendocrine tumors that are often associated with a syndrome characterized by episodic flushing, secretory diarrhea, bronchospasm, and hypotension-the carcinoid syndrome. Cardiac involvement occurs in one-half to two-thirds of patients with carcinoid syndrome and is associated with a worse clinical outcome ...
Wilbert S. Aronow +2 more
openaire +3 more sources
Carcinoid tumors are rare, indolent neuroendocrine tumors that are often associated with a syndrome characterized by episodic flushing, secretory diarrhea, bronchospasm, and hypotension-the carcinoid syndrome. Cardiac involvement occurs in one-half to two-thirds of patients with carcinoid syndrome and is associated with a worse clinical outcome ...
Wilbert S. Aronow +2 more
openaire +3 more sources
International Journal of Cardiology, 2008
The carcinoid syndrome is usually evident when enterochromaffin (EC) cell-derived neuroendocrine tumors (carcinoids) metastasize to the liver. In addition to carcinoid symptomatology, about 40% of patients exhibit carcinoid heart disease (CHD) with fibrotic endocardial plaques and associated heart valve dysfunction. The mechanism behind CHD development
Øyvind Hauso +5 more
openaire +3 more sources
The carcinoid syndrome is usually evident when enterochromaffin (EC) cell-derived neuroendocrine tumors (carcinoids) metastasize to the liver. In addition to carcinoid symptomatology, about 40% of patients exhibit carcinoid heart disease (CHD) with fibrotic endocardial plaques and associated heart valve dysfunction. The mechanism behind CHD development
Øyvind Hauso +5 more
openaire +3 more sources
Carcinoid Heart Disease: a Review
Current Oncology Reports, 2021The development of carcinoid heart disease (CHD) is a fibrotic complication of neuroendocrine neoplasms (NEN) which is associated with a poor prognosis. This review aims to summarise the clinical features, investigations and management of this condition.CHD can affect up to 50% of NET patients with carcinoid syndrome.
Faidon-Marios Laskaratos +2 more
openaire +3 more sources
Carcinoid heart disease: a potentially fatal complication of carcinoid syndrome
BMJ Case Reports, 2023Carcinoid heart disease is a unique and serious cardiac complication of the neuroendocrine tumour that affects the right side of the heart, especially the tricuspid and pulmonic valves, eventually causing right heart failure. We present a middle-aged man
Mustafa Bdiwi +6 more
semanticscholar +1 more source
Clinical Nuclear Medicine
Carcinoid heart disease (Hedinger syndrome) is a long-term consequence in hormone-active neuroendocrine tumors with hepatic metastases and carcinoid syndrome.
C. Laschinsky +4 more
semanticscholar +1 more source
Carcinoid heart disease (Hedinger syndrome) is a long-term consequence in hormone-active neuroendocrine tumors with hepatic metastases and carcinoid syndrome.
C. Laschinsky +4 more
semanticscholar +1 more source
Carcinoid Heart Disease: A Rare Complication of Metastatic Neuroendocrine Tumor
Pakistan Journal of Medical & Health Sciences, 2023Background: Carcinoid heart disease (CHD) is a rare but severe complication of metastatic neuroendocrine tumors (NETs), primarily affecting the right-sided heart valves due to prolonged exposure to vasoactive substances such as serotonin. Objective: This
A. Qasim +5 more
semanticscholar +1 more source
Two- and Three-dimensional Imaging in Carcinoid Heart Disease
Journal of The Indian Academy of Echocardiography & Cardiovascular ImagingA 70-year-old male presented with a history of pedal edema, abdominal distension, and dyspnea on exertion New York Heart Association Class III for cardiology evaluation.
Abhiman B Shetty +2 more
semanticscholar +1 more source
Circulation, 2023
Background: Patients with carcinoid heart disease are prone to the development of mild to severe tricuspid regurgitation with or without accompanying tricuspid stenosis.
Suma Pusapati +2 more
semanticscholar +1 more source
Background: Patients with carcinoid heart disease are prone to the development of mild to severe tricuspid regurgitation with or without accompanying tricuspid stenosis.
Suma Pusapati +2 more
semanticscholar +1 more source
Endocrinology and Metabolism Clinics of North America, 2018
Carcinoid heart disease remains a major cause of morbidity and mortality among patients with carcinoid syndrome and metastatic neuroendocrine tumors. Screening of all patients with N-terminal pro-B-type natriuretic peptide and transthoracic echocardiography is critical for early detection, as early symptoms and signs have low sensitivity for the ...
Martyn Caplin +2 more
openaire +3 more sources
Carcinoid heart disease remains a major cause of morbidity and mortality among patients with carcinoid syndrome and metastatic neuroendocrine tumors. Screening of all patients with N-terminal pro-B-type natriuretic peptide and transthoracic echocardiography is critical for early detection, as early symptoms and signs have low sensitivity for the ...
Martyn Caplin +2 more
openaire +3 more sources
Carcinoid Heart Disease – A 2022 Retrospective
Romanian Journal of Military Medicine, 2023" We aim to introduce a 2022 update on CHD (carcinoid heart disease) considering a multidisciplinary perspective. This is a narrative mini-review. We searched English, full-length papers (PubMed).
C. Nistor +3 more
semanticscholar +1 more source